CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on osteosarcoma, a highly aggressive bone cancer in young individuals. It aims to understand the interactions between osteosarcoma cells and mesenchymal stem cells through exosomes, potentially leading to new therapeutic strategies to combat this disease.
Osteosarcoma (OS) is a very aggressive malignant bone tumor that develops primarily during childhood and adolescence.
It is characterized by rapid growth, a strong tendency for recurrence and an extremely high metastatic potential.
In the last three decades OS survival in the presence of metastasis has stagnated at a dismal 30%, clinical trials proved unsuccessful and no major breakthrough in the treatment of OS has been reported.
To stop OS mortality, alternative therapeutical approaches urgent…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Amsterdam
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
